Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;107(5):1149-1158.
doi: 10.1002/cpt.1764. Epub 2020 Feb 12.

Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7-18 Years

Affiliations

Normalized Testosterone Glucuronide as a Potential Urinary Biomarker for Highly Variable UGT2B17 in Children 7-18 Years

Haeyoung Zhang et al. Clin Pharmacol Ther. 2020 May.

Abstract

UDP-glucuronosyltransferase 2B17 (UGT2B17) is a highly variable androgen-metabolizing and drug-metabolizing enzyme. UGT2B17 exhibits a unique ontogeny profile characterized by a dramatic increase in hepatic protein expression from prepubertal age to adulthood. Age, sex, copy number variation (CNV), and single nucleotide polymorphisms only explain 26% of variability in protein expression, highlighting the need for a phenotypic biomarker for predicting interindividual variability in glucuronidation of UGT2B17 substrates. Here, we propose testosterone glucuronide (TG) normalized by androsterone glucuronide (TG/AG) as a urinary UGT2B17 biomarker, and examine the associations among urinary TG/AG and age, sex, and CNV. We performed targeted metabolomics of 12 androgen conjugates with liquid-chromatography tandem mass spectrometry in 63 pediatric subjects ages 7-18 years followed over 7 visits in 3 years. Consistent with the reported developmental trajectory of UGT2B17 protein expression, urinary TG/AG is significantly associated with age, sex, and CNV. In conclusion, TG/AG shows promise as a phenotypic urinary UGT2B17 biomarker.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All authors declared no competing interests for this work.

Figures

Figure 1.
Figure 1.. Androgen metabolism scheme.
Simplified androgen metabolism scheme, is shown, with relative UGT contribution in glucuronidation depicted in blue. Dashed arrow and box indicate a separately regulated metabolic pathway for epitestosterone and epiandrosterone that is not fully understood.
Figure 2.
Figure 2.. TG, AG, and TG/AG with age and CNV, by sex.
Testosterone glucuronide (TG), androsterone glucuronide (AG), and TG/AG with age is shown in A, B, and C, and TG and AG with copy number variation (CNV) is shown in D and E, respectively. TG/AG with CNV is separated by sexual maturity rating (SMR) at stage 1 (F) and stages 4 and 5 (G), to remove the influence of sexual maturation. Males are depicted in blue triangles and females in pink circles; line and bars show median and interquartile ranges.
Figure 3.
Figure 3.. Association of urinary TG/AG levels with age, sex, race, and CNV.
Model-fitted log (TG/AG) with age splines set at 11 and 14 years is shown with males in blue and females in pink (A). Log (TG/AG) association with race is shown in B, with African Americans (AA) in dark brown and Caucasian Americans (CA) in light brown. Log (TG/AG) association with copy number variation (CNV=0 in light grey, CNV=1 in dark grey, CNV=2 in black) is shown for males (C) and females (D).

Similar articles

Cited by

References

    1. Oda S, Fukami T, Yokoi T & Nakajima M A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development. Drug Metab. Pharmacokinet 30, 30–51 (2015). - PubMed
    1. Xue Y et al. Adaptive evolution of UGT2B17 copy-number variation. Am. J. Hum. Genet 83, 337–346 (2008). - PMC - PubMed
    1. Zhang H et al. Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism. Biochem. Pharmacol 156, 32–42 (2018). - PMC - PubMed
    1. Bhatt DK et al. Hepatic Abundance and Activity of Androgen and Drug Metabolizing Enzyme, UGT2B17, are Associated with Genotype, Age, and Sex. Drug Metab. Dispos dmd.118.080952 (2018).doi:10.1124/dmd.118.080952 - DOI - PMC - PubMed
    1. Bhatt DK et al. Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex. Drug Metab. Dispos 46, 888–896 (2018). - PMC - PubMed

Publication types